Company: SenesTech, Inc.
Ticker: Nasdaq: SNES
Sector: Industrials
Investor Contact: Robert Blum

SenesTech, Inc. News

News

SenesTech Announces Record Second Quarter 2022 Product Sales

Sales up 73% year-over-year and up 42% sequentially PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and...

ContraPest® Shows Dramatic Success in Zoo Deployments

PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest, today released further...

SenesTech Announces Record First Quarter 2022 Product Sales

Sales up 122% Company Launches New Elevate Bait System™ with ContraPest® PHOENIX, May 12, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...

SenesTech Announces Year-End 2021 Financial and Operational Results

Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX, March 29, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors...

Skip to content